Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2024-Q2
добавлен 07.08.2024
Enanta Pharmaceuticals Мультипликаторы 2011-2024 | ENTA
Мультипликаторы по годам Enanta Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.0 | -0.0 | -0.0 | -0.0 | 25.8 | 19.7 | 53.4 | 20.9 | 6.6 | 23.5 | 20.3 | - | - |
P/S |
0.0 | 0.0 | 0.0 | 0.0 | 5.8 | 6.9 | 9.2 | 5.1 | 3.3 | 17.0 | 6.1 | - | - |
EPS |
-6.4 | -5.9 | -3.9 | -1.8 | 2.4 | 3.7 | 0.9 | 1.1 | 4.2 | 1.9 | -0.7 | 1.3 | 1.4 |
EV (Enterprise Value) |
160 млн | 11 млн | -16.4 млн | -55.6 млн | 1.17 млрд | 1.38 млрд | 904 млн | 448 млн | 513 млн | 787 млн | 193 млн | -2.28 млн | 151 млн |
EBITDA per Share |
-6.43 тыс. | -5.87 тыс. | -5.27 тыс. | -1.91 тыс. | 2.04 | 4.72 | 1.4 | 1.72 | 6.68 | 1.05 | 0.945 | - | - |
EV/EBITDA |
-13.1 | -20.6 | 28.6 | 14.9 | 32.9 | 13.4 | 4.0 | 40.3 | 20.1 | - | - | ||
PEG |
0.0 | 0.0 | 0.0 | 0.0 | -0.7 | 0.07 | -2.9 | -0.29 | 0.05 | 0.06 | -0.14 | - | - |
P/B |
0.0 | 0.0 | 0.0 | 0.0 | 2.6 | 3.6 | 3.1 | 1.7 | 2.2 | 5.5 | 1.8 | - | - |
P/CF |
-0.0 | -0.0 | -0.0 | 0.1 | 18.1 | 54.1 | 18.8 | 14.6 | 7.1 | 42.3 | 19.4 | - | - |
ROE % |
-61.74 | -37.89 | -19.78 | -7.94 | 10.03 | 18.28 | 5.87 | 8.03 | 33.45 | 23.17 | 8.71 | - | - |
ROA % |
-28.95 | -32.43 | -18.00 | -7.44 | 9.47 | 17.37 | 5.42 | 7.70 | 32.11 | 22.16 | 8.23 | - | - |
ROCE % |
-63.31 | -38.54 | -27.43 | -9.14 | 7.86 | 22.18 | 8.05 | 11.28 | 51.88 | 12.60 | 8.03 | - | - |
Current Ratio |
1.9 | 6.9 | 11.1 | 15.9 | 17.8 | 23.7 | 11.3 | 29.4 | 25.5 | 22.8 | 23.1 | - | - |
DSO |
66.7 | 93.0 | 88.5 | 111.5 | 91.3 | 118.7 | 37.7 | 53.1 | 35.7 | 34.4 | 18.1 | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
66.7 | 93.0 | 88.5 | 111.5 | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
66.7 | 93.0 | 88.5 | 111.5 | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Enanta Pharmaceuticals
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.07 | -1.47 | -1.58 | - | -1.86 | -1.79 | -1.39 | -4.64 | -1.53 | -1.63 | -1.48 | -2.7 | -1.19 | -1.09 | -0.41 | -1.46 | -0.71 | -0.41 | 0.68 | 0.47 | 0.36 | 0.68 | 1.34 | 1.41 | 1.05 | 1.34 | 0.61 | 1.91 | -0.44 | 0.61 | -0.26 | -0.09 | -0.06 | -0.26 | 1.39 | 0.3 | 0.13 | 1.39 | 2.26 | -0.27 | 2.7 | 2.26 | -0.3 | -0.25 | -0.23 | -0.3 | 1.61 | -4.78 | -4.31 | 2.41 | -4.44 | - | - | - |
EBITDA per Share |
- | - | -1.62 | - | - | - | -1.42 | -4.54 | -1.57 | -1.65 | -1.45 | -3.64 | -1.59 | -1.47 | -0.57 | -0.96 | -1.05 | -0.57 | 0.7 | 1.67 | 0.27 | 0.7 | 1.47 | 2.9 | 1.24 | 1.47 | 0.78 | -1.48 | -0.63 | 0.78 | -0.34 | 1.86 | -0.02 | -0.34 | 1.91 | 6.48 | 0.11 | 1.91 | 3.78 | 1.34 | 1.89 | 3.78 | -0.3 | 1.97 | -0.23 | -0.3 | 18.9 | 23.7 | -3.06 | 29.5 | - | - | - | - |
ROE % |
-67.81 | -69.02 | -64.24 | -40.04 | -69.73 | -62.68 | -58.07 | -56.27 | -40.20 | -36.57 | -32.26 | -26.27 | -14.48 | -10.57 | -7.36 | -2.73 | 1.89 | 6.52 | 11.15 | 14.46 | 17.76 | 21.07 | 24.38 | 21.96 | 27.97 | 19.08 | 16.67 | 11.13 | -1.64 | 0.76 | -4.77 | 7.00 | 10.13 | 11.55 | 24.48 | 36.26 | 30.41 | 63.05 | 80.22 | 53.45 | 52.82 | 15.41 | -17.72 | -9.12 | -1.58 | 5.20 | 6.55 | 6.55 | 3.04 | - | - | - | - | - |
ROA % |
-28.90 | -31.11 | -35.11 | -27.77 | -53.18 | -53.52 | -50.24 | -48.74 | -35.72 | -32.82 | -29.59 | -24.49 | -13.80 | -10.18 | -6.87 | -2.51 | 1.95 | 6.41 | 10.86 | 13.96 | 17.49 | 21.03 | 24.56 | 22.27 | 27.17 | 18.31 | 15.61 | 10.39 | -1.43 | 0.77 | -4.58 | 6.61 | 9.62 | 10.98 | 23.40 | 33.49 | 27.88 | 59.11 | 75.49 | 51.12 | 50.56 | 14.82 | -16.80 | -19.69 | -23.66 | -26.84 | -14.48 | -14.48 | -6.71 | - | - | - | - | - |
ROCE % |
-69.58 | -68.78 | -63.70 | -40.06 | -70.18 | -64.37 | -59.17 | -57.10 | -45.97 | -44.44 | -41.81 | -36.62 | -22.43 | -19.39 | -15.30 | -9.91 | 1.18 | 7.01 | 12.40 | 16.26 | 22.60 | 27.12 | 30.98 | 28.98 | 6.52 | -3.14 | -5.14 | -12.29 | 10.12 | 14.07 | 6.93 | 23.03 | 61.47 | 62.59 | 80.28 | 103.05 | 68.39 | 91.14 | 123.30 | 81.89 | 77.96 | 50.71 | -1.46 | -18.30 | -52.73 | -45.89 | -18.95 | -18.95 | 3.06 | - | - | - | - | - |
Current Ratio |
1.6 | 1.7 | 1.8 | 1.9 | 1.9 | 5.7 | 7.4 | 6.9 | 8.2 | 8.4 | 7.8 | 11.2 | 13.8 | 11.2 | 16.6 | 15.9 | 15.9 | 15.9 | 17.8 | 17.9 | 17.9 | 17.9 | 16.6 | 20.2 | 20.2 | 20.2 | 14.7 | 13.1 | 13.1 | 13.1 | 27.3 | 24.8 | 24.8 | 24.8 | 19.7 | 25.0 | 25.0 | 25.0 | 9.9 | 23.0 | 23.0 | 23.0 | 24.1 | 18.0 | 18.0 | 18.0 | - | 6.3 | 6.3 | - | - | - | - | - |
DSO |
40.5 | 42.6 | 42.5 | - | 88.6 | 103.5 | 83.0 | 27.6 | 89.5 | 113.0 | 84.5 | 28.1 | 95.4 | 125.4 | 79.4 | 90.7 | 114.9 | 109.3 | 90.2 | 91.2 | 105.5 | 105.2 | 89.5 | 91.2 | 107.1 | 93.5 | 40.4 | 12.8 | 128.9 | 107.1 | 101.9 | 91.2 | 83.8 | 134.5 | 31.2 | 96.8 | 120.3 | 86.6 | 46.1 | 59.7 | 3.7 | 1.2 | 55.5 | 54.7 | 44.7 | 41.3 | 1.7 | 51.5 | 18.8 | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
40.5 | 42.6 | 42.5 | - | 88.6 | 103.5 | 83.0 | 27.6 | 89.5 | 113.0 | 84.5 | 28.1 | 95.4 | 125.4 | 79.4 | 90.7 | 114.9 | 109.3 | 90.2 | 91.2 | 105.5 | 105.2 | 89.5 | 91.2 | 107.1 | 93.5 | 40.4 | 12.8 | 128.9 | 107.1 | 101.9 | 91.2 | 83.8 | 134.5 | 31.2 | 96.8 | 120.3 | 86.6 | 46.1 | 59.7 | 3.7 | 1.2 | 55.5 | 54.7 | 44.7 | 41.3 | 1.7 | 51.5 | 18.8 | - | - | - | - | - |
Финансовый цикл |
40.5 | 42.6 | 42.5 | - | 88.6 | 103.5 | 83.0 | 27.6 | 89.5 | 113.0 | 84.5 | 28.1 | 95.4 | 125.4 | 79.4 | 90.7 | 114.9 | 109.3 | 90.2 | 91.2 | 105.5 | 105.2 | 89.5 | 91.2 | 107.1 | 93.5 | 40.4 | 12.8 | 128.9 | 107.1 | 101.9 | 91.2 | 83.8 | 134.5 | 31.2 | 96.8 | 120.3 | 86.6 | 46.1 | 59.7 | 3.7 | 1.2 | 55.5 | 54.7 | 44.7 | 41.3 | 1.7 | 51.5 | 18.8 | - | - | - | - | - |
Все данные представлены в валюте USD